Rheumatology Medical Billing Services

Submit the treatment history in the form reviewers want. That means each prior drug named, how long the patient took it, and specifically why it was stopped, whether ineffective or not tolerated. Requests with only a diagnosis get pended for records, which costs weeks. We build that history once per patient and reuse it for every subsequent request.

Appeal against the plan's own criteria rather than arguing generally. Read the specific requirement the denial cites, then point to where your record satisfies it or explain why the required step is clinically inappropriate for this patient. Documented contraindications carry real weight. Appeals framed this way succeed far more often than letters restating medical necessity.

Log the approval start and end dates on the patient record and check before every cycle. Rheumatology therapy runs for months, appointments move, and an approval quietly lapses in between. Treatment given outside the window is usually unrecoverable, and with biologic costs that is a serious loss. We re-verify before each treatment as standard.

Only if it is recorded at administration. Single-use vials often hold more than the calculated dose, and the discarded portion can be billable when documented properly. Practices that record only the administered amount give the remainder away on every treatment. Capturing both figures at the chair turns a routine loss into recoverable revenue.

It depends on the specific injection code, because some already include guidance. Adding a separate line when it is bundled triggers a correct coding edit. Where guidance is genuinely separate, it should be billed and often is not. We resolve this at coding, which both protects the claim and captures the value where it exists.

Yes, when your practice performs it. Ongoing surveillance is required for many rheumatology therapies, and it is a distinct service from the office visit. Practices that run monitoring as a routine background task often never charge for it. We reconcile the monitoring schedule against submitted claims monthly, which usually recovers a steady amount.

Frequently. A patient with active rheumatoid arthritis, a therapy change, and monitoring review represents substantial decision making, yet these visits are often billed at a middle level. We audit a sample of notes against the level supported. Recording total time gives you a second path when a visit runs long on counselling.

Screen for manufacturer and foundation assistance before treatment starts. Biologic cost sharing can be substantial, and patients who cannot pay often simply stop therapy, which is bad clinically and financially. Many programmes require enrolment before the first dose. We build the screen into the pre-treatment workflow rather than reacting to an unpaid balance.

Yes, and that is where the financial stakes are highest. An infusion suite means your practice carries drug acquisition cost before payment arrives. We verify coverage and approval before ordering, reconcile every dose against the administration record, and report drug margin separately so you can see which therapies are genuinely sustainable.

A standard step therapy packet. Most delayed and denied biologic requests fail on incomplete history rather than genuine ineligibility. Defining exactly what each request must contain, then submitting that every time, shortens approval cycles and reduces denials within the first quarter. It also makes appeals far stronger when they are still needed.